Letter: Management of lipoatrophic diabetes.
D000273:Adipose Tissue / Q000473:pathology; D001284:Atrophy; D002648:Child; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000503:physiopathology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy; D004027:Diencephalon / Q000503:physiopathology; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D008060:Lipodystrophy / Q000188:drug therapy* / Q000503:physiopathology; D010868:Pimozide / Q000627:therapeutic use*; D013997:Time Factors
D010868:Pimozide